NEULAND LABORATORIES
Midcap | BSE
Sector
Index
Here's the live share price of Neuland Laboratories along with daily highs, lows, percentage changes and volume trends, and, all financial information.
0.71₹ 119.05
As on Jun 08, 2026, 02:22 PM IST
Source: Dion Global
Neuland Laboratories Price Performance
Today's LowToday's High
₹16,478.45₹17,027.85
₹16,931.95
52 Weeks' Low52 Weeks' High
₹11,500.00₹19,748.40
₹16,931.95
Open Price
₹16,539.40
Prev. Close
₹16,812.90
Volume
1,468
Source: Dion Global
Neuland Laboratories Peer Comparision
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Neuland Laboratories | -0.77 | -0.21 | 30.02 | 5.49 | 29.91 | 79.81 | 52.69 |
| Sun Pharmaceutical Industries | -0.38 | -3.05 | -0.28 | -0.07 | 6.79 | 20.98 | 21.60 |
| Divi's Laboratories | -1.48 | -2.16 | 3.70 | 3.68 | 0.15 | 22.92 | 9.19 |
| Torrent Pharmaceuticals | 1.08 | 1.93 | 3.10 | 18.19 | 40.80 | 35.37 | 25.73 |
| Cipla | -0.46 | 1.96 | 5.31 | -7.04 | -7.43 | 12.68 | 8.14 |
| Zydus Lifesciences | 1.14 | 16.06 | 19.39 | 17.92 | 13.54 | 28.39 | 11.39 |
| Dr. Reddy's Laboratories | -1.57 | -2.13 | -1.64 | 1.22 | -2.87 | 11.35 | 4.16 |
| Lupin | -0.24 | -7.18 | -3.30 | 9.45 | 13.40 | 40.27 | 12.94 |
| Mankind Pharma | -1.08 | -0.42 | 7.57 | 7.63 | -0.04 | 16.44 | 10.57 |
| Aurobindo Pharma | 2.15 | -1.46 | 18.68 | 24.23 | 25.93 | 30.09 | 8.79 |
| Laurus Labs | 4.95 | 21.46 | 39.35 | 42.33 | 122.66 | 61.08 | 20.10 |
| Biocon | -3.67 | 8.35 | 5.66 | 7.42 | 24.98 | 19.27 | 1.19 |
| Alkem Laboratories | -2.31 | -3.05 | -3.05 | -4.08 | 10.40 | 16.61 | 11.34 |
| Glenmark Pharmaceuticals | -3.77 | -7.81 | 3.12 | 14.04 | 37.64 | 51.47 | 28.90 |
| Abbott India | -3.37 | -1.24 | -5.03 | -9.26 | -18.21 | 5.96 | 10.31 |
| Anthem Biosciences | 0.86 | -0.23 | 15.97 | 18.28 | 4.96 | 1.69 | 1.01 |
| Ipca Laboratories | 9.22 | 5.67 | 10.86 | 14.00 | 20.61 | 30.30 | 10.12 |
| Gland Pharma | 1.12 | 25.51 | 36.31 | 33.59 | 38.66 | 34.29 | -6.10 |
| Ajanta Pharma | 2.11 | -3.93 | -0.64 | 11.69 | 15.66 | 28.07 | 17.91 |
| GlaxoSmithKline Pharmaceuticals | -2.02 | -10.74 | -13.88 | -14.92 | -36.94 | 16.04 | 7.76 |
Source: Dion Global
Over the last one year, Neuland Laboratories has gained 29.91% compared to peers like Sun Pharmaceutical Industries (6.79%), Divi's Laboratories (0.15%), Torrent Pharmaceuticals (40.80%). From a 5 year perspective, Neuland Laboratories has outperformed peers relative to Sun Pharmaceutical Industries (21.60%) and Divi's Laboratories (9.19%).
Neuland Laboratories Financials
Source: Dion Global
Neuland Laboratories Stock Technicals
Moving Average
| Day | SMA | EMA |
|---|---|---|
| 5 | 16,959.04 | 16,897.66 |
| 10 | 16,905.58 | 16,872.91 |
| 20 | 16,871.62 | 16,638.36 |
| 50 | 15,283.79 | 15,710.96 |
| 100 | 14,278.54 | 15,079.03 |
| 200 | 14,945.78 | 14,585.98 |
Source: Dion Global
Neuland Laboratories Share Holding Pattern
In the latest quarter, Neuland Laboratories remained same as its previous close in promoter holding, while DII stake increased to 15.84%, FII holding fell to 20.46%, and public shareholding moved down to 31.08% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Neuland Laboratories Stock Mutual Fund Holdings
Fund Name | No. Of Shares | % of AUM | Amount Invested(in ₹ crore) |
|---|---|---|---|
| 2,69,243 | 1.93 | 403.95 | |
| 1,61,529 | 1.48 | 242.34 | |
| 93,734 | 2.18 | 140.63 | |
| 68,758 | 2.31 | 103.16 | |
| 57,513 | 0.34 | 86.29 | |
| 45,345 | 0.1 | 68.03 | |
| 44,855 | 1.89 | 67.3 | |
| 32,160 | 0.81 | 48.25 | |
| 26,997 | 1.38 | 40.5 | |
| 26,199 | 0.5 | 39.31 |
Source: Dion Global
* Excluding Index & Arbitrage Funds
Neuland Laboratories Corporate Actions
Date Time | Announcement |
|---|---|
| Jun 05, 2026, 03:37 PM IST IST | Neuland Laboratories - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation |
| Jun 03, 2026, 08:30 PM IST IST | Neuland Laboratories - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation |
| Jun 01, 2026, 12:45 AM IST IST | Neuland Laboratories - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation |
| May 22, 2026, 10:05 PM IST IST | Neuland Laboratories - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation |
| May 16, 2026, 09:43 PM IST IST | Neuland Laboratories - Announcement under Regulation 30 (LODR)-Earnings Call Transcript |
Source: Dion Global
About Neuland Laboratories
Neuland Laboratories Ltd. is a Public Limited Listed company incorporated on 07/01/1984 and has its registered office in the State of Telangana, India. Company's Corporate Identification Number(CIN) is L85195TG1984PLC004393 and registration number is 004393. Currently Company is involved in the business activities of Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.. Company's Total Operating Revenue is Rs. 2022.99 Cr. and Equity Capital is Rs. 12.90 Cr. for the Year ended 31/03/2026.
- IndustryPharmaceuticals
- Address11th Floor (5th Office Level), Phoenix IVY Building, Hyderabad Telangana 500033
- Contact
Source: Dion Global
Management
- Dr. Davuluri Rama Mohan RaoExecutive Chairman
- Mr. Davuluri Sucheth RaoVice Chairman & CEO
- Mr. Davuluri Saharsh RaoVice Chairman & Mng.Director
- Dr. Christopher M CimarustiNon Executive Director
- Mr. Homi Rustum KhusrokhanInd. Non-Executive Director
- Mr. Prasad Raghava MenonInd. Non-Executive Director
- Mr. Sugata SircarInd. Non-Executive Director
- Ms. Pallavi Joshi BakhruInd. Non-Executive Director
FAQs on Neuland Laboratories Share Price
What is the share price of Neuland Laboratories?
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Neuland Laboratories is ₹16,931.95 as on Jun 08, 2026.
What kind of stock is Neuland Laboratories?
The Neuland Laboratories is operating in the Pharmaceuticals and health care Sector. It is classified as a Midcap stock on the BSE.
What is the Market Cap of Neuland Laboratories?
The market cap of Neuland Laboratories is ₹21,729.08 Cr as on Jun 08, 2026.
What are today's High and Low prices of Neuland Laboratories?
Today’s highest and lowest price of Neuland Laboratories are ₹17,027.85 and ₹16,478.45.
What are the 52 Week High and 52 Week Low of Neuland Laboratories?
The 52-week high/low is the highest and lowest price at which Neuland Laboratories stock has traded in the past 52-week or nearly a year. The 52-week high of Neuland Laboratories is ₹19,748.40 and 52-week low of Neuland Laboratories is ₹11,500.00 as on Jun 08, 2026.
How has the Neuland Laboratories performed historically in terms of returns?
The Neuland Laboratories has shown returns of 0.72% over the past day, -0.22% for the past month, 30.0% over 3 months, 29.89% over 1 year, 79.8% across 3 years, and 52.69% over 5 years.
What are the P/E ratio, dividend yield and PB ratio of Neuland Laboratories?
P/E ratio of and PB ratio of Neuland Laboratories are 59.70 and 13.08 on Jun 08, 2026. While the company gives a dividend yield of 0.20 per annum.
Source: Dion Global
Neuland Laboratories News
✕